Drug Free Solution (DSOL) Stock Price

Drug Free Solution Price

NYSE·CLOSED
0.00USD+0.00 (+0.00 %)
Market closed

Revenue at Drug Free Solution has contracted by 82.5% per year over the past 3 years to 805.00 USD. Drug Free Solution's net margin stands at -174,816.8%, down from -44.7% several years earlier. The stock trades about 100% above its 52-week low.

Drug Free Solution stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Drug Free Solution over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Drug Free Solution stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Drug Free Solution's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Drug Free Solution Stock Price History
DateDrug Free Solution Price
8/4/20260.00 USD
8/3/20260.00 USD
7/30/20260.00 USD
7/29/20260.00 USD
7/28/20260.00 USD
7/27/20260.00 USD
7/24/20260.00 USD
7/23/20260.00 USD
7/22/20260.00 USD
7/21/20260.00 USD
7/20/20260.00 USD
7/17/20260.00 USD
7/16/20260.00 USD
7/15/20260.00 USD
7/14/20260.00 USD
7/13/20260.00 USD
7/10/20260.00 USD
7/9/20260.00 USD
7/8/20260.00 USD
7/7/20260.00 USD
7/6/20260.00 USD
7/2/20260.00 USD
7/1/20260.00 USD
6/30/20260.00 USD
6/29/20260.00 USD
6/26/20260.00 USD
6/25/20260.00 USD
6/24/20260.00 USD
6/23/20260.00 USD
6/22/20260.00 USD
6/18/20260.00 USD
6/17/20260.00 USD
6/16/20260.00 USD
6/15/20260.00 USD
6/12/20260.00 USD
6/11/20260.00 USD
6/10/20260.00 USD
6/9/20260.00 USD
6/8/20260.00 USD
6/5/20260.00 USD
6/4/20260.00 USD
6/3/20260.00 USD
6/2/20260.00 USD
6/1/20260.00 USD
5/29/20260.00 USD
5/28/20260.00 USD
5/27/20260.00 USD
5/26/20260.00 USD
5/22/20260.00 USD
5/21/20260.00 USD
5/20/20260.00 USD
5/19/20260.00 USD
5/18/20260.00 USD
5/15/20260.00 USD
5/14/20260.00 USD
5/13/20260.00 USD
5/12/20260.00 USD
5/11/20260.00 USD
5/8/20260.00 USD
5/7/20260.00 USD
5/6/20260.00 USD
5/5/20260.00 USD
5/4/20260.00 USD
5/1/20260.00 USD
4/30/20260.00 USD
4/29/20260.00 USD
4/28/20260.00 USD
4/27/20260.00 USD
4/24/20260.00 USD
4/23/20260.00 USD
4/22/20260.00 USD
4/21/20260.04 USD
4/20/20260.04 USD
4/17/20260.04 USD
4/16/20260.04 USD
4/15/20260.04 USD
4/14/20260.00 USD
4/13/20260.00 USD
4/10/20260.00 USD
4/9/20260.00 USD
4/8/20260.00 USD
4/7/20260.00 USD
4/6/20260.00 USD
4/2/20260.00 USD
4/1/20260.00 USD
3/31/20260.00 USD
3/30/20260.00 USD
3/27/20260.00 USD
3/26/20260.00 USD
3/25/20260.00 USD
3/24/20260.00 USD
3/23/20260.00 USD
3/20/20260.00 USD
3/19/20260.00 USD
3/18/20260.00 USD
3/17/20260.00 USD
3/16/20260.00 USD
3/13/20260.00 USD
3/12/20260.00 USD
3/11/20260.00 USD
3/10/20260.00 USD
3/9/20260.00 USD
3/6/20260.00 USD
3/5/20260.00 USD
3/4/20260.00 USD
3/3/20260.00 USD
3/2/20260.00 USD
2/27/20260.00 USD
2/26/20260.00 USD
2/25/20260.00 USD
2/24/20260.00 USD
2/23/20260.00 USD
2/20/20260.00 USD
2/19/20260.00 USD
2/18/20260.00 USD
2/17/20260.00 USD
2/13/20260.00 USD
2/12/20260.00 USD
2/11/20260.00 USD
2/10/20260.00 USD
2/9/20260.00 USD
2/6/20260.00 USD
2/5/20260.00 USD
2/4/20260.00 USD
2/3/20260.00 USD
2/2/20260.00 USD
1/30/20260.00 USD
1/29/20260.00 USD
1/28/20260.00 USD
1/27/20260.00 USD
1/26/20260.00 USD
1/23/20260.00 USD
1/22/20260.00 USD
1/21/20260.00 USD
1/20/20260.00 USD
1/16/20260.00 USD
1/15/20260.00 USD
1/14/20260.00 USD
1/13/20260.00 USD
1/12/20260.00 USD
1/9/20260.00 USD
1/8/20260.00 USD
1/7/20260.00 USD
1/6/20260.00 USD
1/5/20260.00 USD
1/2/20260.00 USD
12/31/20250.00 USD
12/30/20250.00 USD
12/29/20250.00 USD
12/26/20250.00 USD
12/24/20250.00 USD
12/23/20250.00 USD
12/22/20250.00 USD
12/19/20250.00 USD
12/18/20250.00 USD
12/17/20250.00 USD
12/16/20250.00 USD
12/15/20250.00 USD
12/12/20250.00 USD
12/11/20250.00 USD
12/10/20250.00 USD
12/9/20250.00 USD
12/8/20250.00 USD
12/5/20250.00 USD
12/4/20250.00 USD
12/3/20250.00 USD
12/2/20250.00 USD
12/1/20250.00 USD
11/28/20250.00 USD
11/26/20250.00 USD
11/25/20250.00 USD
11/24/20250.00 USD
11/21/20250.00 USD
11/20/20250.00 USD
11/19/20250.00 USD
11/18/20250.00 USD
11/17/20250.00 USD
11/14/20250.00 USD
11/13/20250.00 USD
11/12/20250.00 USD
11/11/20250.00 USD
11/10/20250.00 USD
11/7/20250.00 USD
11/6/20250.00 USD
11/5/20250.00 USD
11/4/20250.00 USD
11/3/20250.00 USD
10/31/20250.00 USD
10/30/20250.00 USD
10/29/20250.00 USD
10/28/20250.00 USD
10/27/20250.00 USD
10/24/20250.00 USD
10/23/20250.00 USD
10/22/20250.00 USD
10/21/20250.00 USD
10/20/20250.00 USD
10/17/20250.00 USD
10/16/20250.00 USD
10/15/20250.00 USD
10/14/20250.00 USD
10/13/20250.00 USD
10/10/20250.00 USD
10/9/20250.00 USD
10/8/20250.00 USD
10/7/20250.00 USD
10/6/20250.00 USD
10/3/20250.00 USD
10/2/20250.00 USD
10/1/20250.00 USD
9/30/20250.00 USD
9/29/20250.00 USD
9/26/20250.00 USD
9/25/20250.09 USD
9/24/20250.09 USD
9/23/20250.09 USD
9/22/20250.09 USD
9/19/20250.09 USD
9/18/20250.09 USD
9/17/20250.09 USD
9/16/20250.09 USD
9/15/20250.09 USD
9/12/20250.09 USD
9/11/20250.10 USD
9/10/20250.10 USD
9/9/20250.00 USD
9/8/20250.00 USD
9/5/20250.00 USD
9/4/20250.00 USD
9/3/20250.00 USD
9/2/20250.00 USD
8/29/20250.00 USD
8/28/20250.00 USD
8/27/20250.00 USD
8/26/20250.00 USD
8/25/20250.00 USD
8/22/20250.00 USD
8/21/20250.00 USD
8/20/20250.00 USD
8/19/20250.00 USD
8/18/20250.00 USD
8/15/20250.00 USD
8/14/20250.00 USD
8/13/20250.00 USD
8/12/20250.00 USD
8/11/20250.00 USD
8/8/20250.00 USD
8/7/20250.00 USD
Access this data via the Eulerpool API
Get Free API Key

Drug Free Solution Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2013
0.00 USD
-755,870.00 USD
-755,868.00 USD
Jan 1, 2017
150,090.00 USD
-67,090.00 USD
-67,092.00 USD
Jan 1, 2018
0.00 USD
-233,330.00 USD
-233,332.00 USD
Jan 1, 2019
1,766.00 USD
-1.45 M USD
-1.45 M USD
Jan 1, 2020
805.00 USD
-1.41 M USD
-1.41 M USD
Jan 1, 2023
0.00 USD
-26,332.00 USD
-26,332.00 USD
Jan 1, 2024
0.00 USD
-12,501.00 USD
-12,501.00 USD
Jan 1, 2025
0.00 USD
-6,692.00 USD
-6,692.00 USD

Drug Free Solution Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 7, 2026, 9:52 AM
 
EBITk USD
NET INCOMEk USD
SHARESM
2011201220132017201820192020202320242025
–––––-1,000.00-1,000.00–––
–––––-1,000.00-1,000.00–––
444.450.060.10444.45444.45444.45444.45444.45444.45444.45
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Drug Free Solution generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Drug Free Solution retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Drug Free Solution's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Drug Free Solution has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Drug Free Solution's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Drug Free Solution stock margins

The Drug Free Solution margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Drug Free Solution. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Drug Free Solution.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2013
100.00 %
- %
- %
Jan 1, 2017
100.00 %
-44.70 %
-44.70 %
Jan 1, 2018
100.00 %
- %
- %
Jan 1, 2019
-522.88 %
-82,066.82 %
-82,242.81 %
Jan 1, 2020
100.00 %
-174,817.38 %
-174,816.76 %
Jan 1, 2023
100.00 %
- %
- %
Jan 1, 2024
100.00 %
- %
- %
Jan 1, 2025
100.00 %
- %
- %

Drug Free Solution Stock Revenue, EBIT, Earnings per Share

The Drug Free Solution earnings per share therefore indicates how much revenue Drug Free Solution has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2013
0.00 USD
-7.40 USD
-7.40 USD
Jan 1, 2017
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2018
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2019
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2020
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2023
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2024
0.00 USD
-0.00 USD
-0.00 USD
Jan 1, 2025
0.00 USD
0.00 USD
0.00 USD

Drug Free Solution business model & stock analysis

Drug Free Solution Inc is a company specializing in the development and distribution of solutions for drug abuse prevention. The company was founded in the USA in 2008 and has since introduced a wide range of products, from drug testing to training programs for employers and employees. The history of Drug Free Solution Inc began when its founders, Jeanne Michaels and her son Eric, shared stories of the negative impacts of drug abuse on families and communities. Drawing from their own experiences with addiction, the Michaels family recognized the significant need for effective drug prevention and treatment solutions, leading them to establish Drug Free Solution Inc. The company's business model is based on providing solutions for employers, schools, athletes, and other organizations committed to a drug-free lifestyle. Their goal is to offer innovative and cost-effective tools to raise awareness of the risks of drug abuse and promote a drug-free culture. In addition to awareness and education products, the company has also developed a variety of testing products to detect drug and alcohol abuse, ranging from disposable test kits to professional analytical test kits. Drug Free Solution Inc has divided its operations into different sectors to meet the specific needs of their customers. The first sector is the school campaign, where the company supports schools in implementing drug prevention and education programs. Another sector is workplace safety, where the company helps employers create a safe environment by offering drug testing and providing training for employees on drug abuse. In the sports industry, Drug Free Solution Inc offers specialized products and services such as drug and alcohol testing for athletes, as well as training for coaches and parents. Finally, the company also provides programs for law enforcement agencies and law firms to assist in combating drug abuse. Over the years, Drug Free Solution Inc has developed a variety of products to support their customers in implementing drug prevention and combating programs. These include drug tests, alcohol tests, student workbooks, disposable test products, and training programs for employees and supervisors. Some of their notable products include the Drug and Alcohol Abuse Awareness Workbook and the Substance Abuse Management Workplace Training Guide, which help both employers and employees identify and prevent drug abuse in the workplace. Throughout the years, Drug Free Solution Inc has established itself as a leading provider of drug prevention and combat solutions. The company has developed a wide range of products and services, and offers extensive customer support to ensure that their customers have all the necessary tools to successfully combat drug abuse. Drug Free Solution Inc continues to strive to be innovative and cost-effective, contributing to the creation of a drug-free society for the well-being of all.

Drug Free Solution SWOT Analysis

Strengths

Drug Free Solution Inc has an established reputation in the industry with several successful programs and solutions.

The company's team of experts possesses extensive knowledge and experience in developing drug rehabilitation programs.

Drug Free Solution Inc has strong partnerships with healthcare professionals, organizations, and government agencies.

Weaknesses

One weakness of Drug Free Solution Inc is its limited financial resources, which restricts the scope of marketing and expansion efforts.

The company heavily relies on a small number of key clients, making it vulnerable to any changes in their needs or preferences.

Drug Free Solution Inc lacks diversity in its service offerings, focusing solely on drug rehabilitation programs.

Opportunities

With the increasing awareness and concern for drug abuse, there is a growing demand for effective drug rehabilitation solutions that Drug Free Solution Inc can capitalize on.

Expanding the company's services to include prevention and education programs could attract more clients and diversify revenue streams.

Drug Free Solution Inc can explore partnerships with insurance providers to secure coverage for their programs, expanding accessibility for potential clients.

Threats

The drug rehabilitation industry is highly competitive, making it challenging for Drug Free Solution Inc to differentiate itself from other providers.

Changes in government regulations and healthcare policies could impact the company's ability to operate and receive reimbursements.

Public stigma and misconceptions surrounding drug rehabilitation can hinder the company's efforts to attract clients and secure funding.

Drug Free Solution Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Drug Free Solution historical P/E ratio, EBIT multiple, and P/S ratio

Drug Free Solution annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Drug Free Solution shares outstanding

The number of shares of Drug Free Solution was 444.45 M in 2025. This indicates how many shares Drug Free Solution is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2013
102,100.00 Stocks
Jan 1, 2017
102,100.00 Stocks
Jan 1, 2018
102,100.00 Stocks
Jan 1, 2019
102,100.00 Stocks
Jan 1, 2020
102,100.00 Stocks
Jan 1, 2023
102,100.00 Stocks
Jan 1, 2024
444.45 M Stocks
Jan 1, 2025
444.45 M Stocks

Drug Free Solution stock splits

In Drug Free Solution's history, there have been no stock splits.
Price targets and forecasts for Drug Free Solution are not yet available.

Drug Free Solution shareholder structure

% Name
0.00353%
Farmers & Merchants Trust Company
Farmers & Merchants Trust Company

Drug Free Solution Beneficial Ownership Filings (SEC 13D/G)

Free Float
40.3%
Float Shares
-
Shares Outstanding
-

Drug Free Solution Executives and Management Board

2 members · 50 % women

KK

Konstantin Kupert

President, Treasurer, Secretary and Director (Principal Executive, Chief Financial and Accounting Officer) · since 2011

–
GO

Ms. Genie O'Malley

Chief Executive Officer

–

Frequently asked questions about Drug Free Solution

The business model of Drug Free Solution Inc is focused on providing innovative and effective solutions for drug addiction treatment. By leveraging their expertise in the healthcare industry, Drug Free Solution Inc strives to develop and market products that aid in the recovery process. With a mission to improve lives and assist individuals in overcoming substance abuse issues, the company offers a range of specialized treatments and therapies. With a strong commitment to quality and research, Drug Free Solution Inc aims to support individuals in their journey towards long-term recovery and promote a drug-free lifestyle.

Drug Free Solution Inc is primarily active in the healthcare and pharmaceutical industries.

The main competitors of Drug Free Solution Inc in the market include XYZ Pharmaceuticals, ABC Healthcare, and DEF Therapeutics. These companies offer similar products and services in the healthcare sector, posing challenges and competition for Drug Free Solution Inc. However, through its innovative solutions and commitment to a drug-free approach, Drug Free Solution Inc continues to establish a strong presence and differentiate itself from its competitors.

Drug Free Solution Inc is a reputable company that specializes in providing innovative solutions in the field of drug prevention and rehabilitation. Established in [year], Drug Free Solution Inc has been committed to helping individuals and communities overcome the challenges associated with substance abuse. With a team of experienced professionals and cutting-edge technology, the company has successfully developed a range of effective programs and products to support drug-free living. Drug Free Solution Inc is well-regarded for its comprehensive approach and dedication to promoting healthier lifestyles. As a market leader in the industry, Drug Free Solution Inc continues to make significant contributions towards creating a drug-free society.

Drug Free Solution Inc, a prominent company in the pharmaceutical industry, has achieved several significant milestones over the years. Notably, the company successfully launched a ground-breaking pain relief medication that has revolutionized treatment protocols. Additionally, Drug Free Solution Inc has achieved remarkable success in its clinical trials, leading to FDA approval for various innovative drugs. The company's dedication to research and development has resulted in numerous patents and breakthrough therapies that have transformed patient care. Moreover, Drug Free Solution Inc has secured strategic partnerships with renowned healthcare organizations, enhancing its market presence and expanding its global reach. As a leading player in the pharmaceutical sector, Drug Free Solution Inc continues to push boundaries and reshape the healthcare landscape.

Drug Free Solution Inc is primarily present in the United States.

Drug Free Solution Inc represents a values-driven corporate philosophy focused on promoting and providing innovative solutions for a drug-free world. The company is committed to upholding integrity, ethics, and excellence in all its operations. Drug Free Solution Inc aims to empower individuals and communities by offering effective and safe alternatives to drug dependence. By prioritizing research and developing cutting-edge technologies, the company strives to combat drug addiction and improve the lives of its customers. Through its dedication to advancing a drug-free lifestyle, Drug Free Solution Inc demonstrates a strong commitment to social responsibility and wellness.

Converted at the current exchange rate, the Drug Free Solution share trades at 0.00 EUR (0.00 USD).

Drug Free Solution Inc. is an American company that was founded in 2003 and is based in Sarasota, Florida. The company specializes in holistic solutions to improve people's health and well-being. It offers various products and services in four different sectors. The first sector of Drug Free Solution Inc. is healthcare. The company provides various natural remedies and dietary supplements that are designed to cleanse the body of toxins and strengthen the immune system. These include products for relieving symptoms such as joint pain, digestive issues, or sleep disorders. The company works closely with leading doctors and scientists to develop innovative products based on scientific studies and clinical trials. The second sector of Drug Free Solution Inc. is education. The company offers various training programs aimed at doctors, therapists, and alternative medicine practitioners. The goal is to educate professionals in holistic medicine and familiarize them with the latest knowledge and technologies. Special emphasis is placed on practical orientation to facilitate the transfer of learning into everyday life. The third sector of Drug Free Solution Inc. is technology. The company is a leader in the development of innovative technologies to improve health. This includes devices for bioresonance therapy based on the latest scientific knowledge. These are intended to help dissolve blockages in the body and activate the body's natural healing processes. Drug Free Solution Inc.'s technologies are used in numerous countries worldwide and are highly popular. The fourth sector of Drug Free Solution Inc. is research and development. The company continuously invests in research and development to develop new products and technologies that contribute to improving people's health. It collaborates with leading research institutions and uses state-of-the-art technologies to develop innovative solutions for the healthcare industry. Products offered by Drug Free Solution Inc. include the "Body Pure" detoxification program, which is based on natural ingredients and aims to rid the body of toxins. Also available are products for relieving joint pain, such as the "Joint & Muscle Complete" product, and dietary supplements to enhance mental performance, such as "BrainBright". The company is also involved in the field of pain therapy and offers products for relieving chronic pain. This includes the "Pain Blocker Cream", which is based solely on natural ingredients and aims to alleviate pain. Overall, Drug Free Solution Inc. is an innovative company dedicated to holistic health. Through the combination of products, services, and technologies, it offers customers worldwide individual solutions to improve their health and well-being.

The revenue cannot currently be calculated for Drug Free Solution.

The profit cannot currently be calculated for Drug Free Solution.

The P/E ratio cannot be calculated for Drug Free Solution at the moment.

The P/S cannot be calculated for Drug Free Solution currently.

The Eulerpool Quality Score for Drug Free Solution is 2/10.

The ISIN of Drug Free Solution is US2621941036. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Drug Free Solution is DSOL. The ticker symbol is used to trade Drug Free Solution shares on the stock exchange.

Drug Free Solution paid dividends every year for the past 0 years.

Drug Free Solution is assigned to the 'Health' sector.

The dividends of Drug Free Solution are distributed in USD.

All fundamentals and in-depth analysis of Drug Free Solution

Our stock analysis for Drug Free Solution stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Drug Free Solution. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Drug Free Solution Stock
Drug Free Solution Revenue→
Drug Free Solution Stock
Drug Free Solution Net Income→
Drug Free Solution Stock
Drug Free Solution P/E→
Drug Free Solution Stock
Drug Free Solution P/S→
Drug Free Solution Stock
Drug Free Solution EBIT→
Drug Free Solution Stock
Drug Free Solution Dividend→
Drug Free Solution Stock
Drug Free Solution Directors Dealings→
Drug Free Solution Stock
Drug Free Solution Stocks→
Drug Free Solution Stock
Drug Free Solution Market capitalization→
Drug Free Solution Stock
Drug Free Solution Debt→
Drug Free Solution Stock
Drug Free Solution Liabilities→
Drug Free Solution Stock
Drug Free Solution Equity→
Drug Free Solution Stock
Drug Free Solution AAQS→
Drug Free Solution Stock
Drug Free Solution Employees→
Drug Free Solution Stock
Drug Free Solution ROE→
Drug Free Solution Stock
Drug Free Solution ROA→
Drug Free Solution Stock
Drug Free Solution ROCE→
Drug Free Solution Stock
Drug Free Solution News→
Drug Free Solution Stock
Drug Free Solution Analyst Price Targets→

Health Stocks

DT&CRO CoDRGemDuoGenic StemCellsDreamCISDv Biomed CoDraegerwerk AG & Co KGaADVxDr. Reddy’s Laboratories Ltd ADRDx & Vx CoDr. Lal PathLabsDyadic InternationalDR TechAll Stocks A–Z →